Categories

Top sellers

Подкатегории

Active filters

Evalar Bio tea gastrointestinal 20 filter packs

Tablets. The active ingredient is trimebutine (trimebutin). A drug for the treatment of functional disorders of the gastrointestinal tract.

Tablets. The active ingredient is trimebutine (trimebutin). A drug for the treatment of functional disorders of the gastrointestinal tract.

Tablets. The active ingredient is trimebutine (trimebutin). A drug for the treatment of functional disorders of the gastrointestinal tract.

Tablets. The active ingredient is trimebutine (trimebutin). A drug for the treatment of functional disorders of the gastrointestinal tract.

Extended-release tablets. An anti-inflammatory drug used to treat Crohn's disease and ulcerative colitis. It has a local anti-inflammatory effect due to inhibition of the activity of neutrophilic lipoxygenase and the synthesis of prostaglandins and leukotrienes. Slows down migration, degranulation, phagocytosis of neutrophils, as well as the secretion of immunoglobulins by lymphocytes.

Suppositories for rectal administration. The active substance is mesalazine. The drug reduces the formation of leukotrienes and cytokinins, neutralizes free radicals, inhibits chemotaxis of leukocytes.

Extended-release tablets. An anti-inflammatory drug used to treat Crohn's disease and ulcerative colitis. It has a local anti-inflammatory effect due to inhibition of the activity of neutrophilic lipoxygenase and the synthesis of prostaglandins and leukotrienes. Slows down migration, degranulation, phagocytosis of neutrophils, as well as the secretion of immunoglobulins by lymphocytes.

Enteric-coated tablets. The active substance is mesalazine. An anti-inflammatory drug used to treat Crohn's disease and ulcerative colitis.

Enteric-coated tablets. The active substance is mesalazine. An anti-inflammatory drug used to treat Crohn's disease and ulcerative colitis.

Enteric-coated tablets. The active substance is mesalazine. An anti-inflammatory drug used to treat Crohn's disease and ulcerative colitis.

Enteric-coated tablets. The active substance is mesalazine. An anti-inflammatory drug used to treat Crohn's disease and ulcerative colitis.

Enteric-coated tablets. The active substance is mesalazine. An anti-inflammatory drug used to treat Crohn's disease and ulcerative colitis.

Enteric-coated tablets. The active substance is mesalazine. An anti-inflammatory drug used to treat Crohn's disease and ulcerative colitis.

Для условий с повышенной потребностью витаминов группы В.

Tablets. The active substance is glipizide. Stimulates insulin secretion by beta cells of the islet apparatus of the pancreas. Reduces blood glucose levels by stimulating the release of insulin from the pancreas; enhances the insulinotropic effect of food in diabetic patients.

Tablets. The active substance is glipizide. Stimulates insulin secretion by beta cells of the islet apparatus of the pancreas. Reduces blood glucose levels by stimulating the release of insulin from the pancreas; enhances the insulinotropic effect of food in diabetic patients.

Tablets. The active substance is acarbose. Acarbose is a hypoglycemic drug, an alpha-glucosidase inhibitor that inhibits the digestion and absorption of carbohydrates in the small intestine and, as a result, reduces the increase in blood glucose concentration after eating carbohydrate-containing foods. It is prescribed for oral administration to patients with non-insulin-dependent diabetes mellitus in cases where dietary changes or other hypoglycemic agents do not provide effective control over their condition.

Tablets. The active substance is acarbose. Acarbose is a hypoglycemic drug, an alpha-glucosidase inhibitor that inhibits the digestion and absorption of carbohydrates in the small intestine and, as a result, reduces the increase in blood glucose concentration after eating carbohydrate-containing foods. It is prescribed for oral administration to patients with non-insulin-dependent diabetes mellitus in cases where dietary changes or other hypoglycemic agents do not provide effective control over their condition.

Film-coated tablets. The active substance is ursodeoxycholic acid. Hepatoprotector with choleretic and cholelitholytic action. It has a choleretic, cholelitholytic, hypolipidemic, hypocholesterolemic and immunomodulatory effect.

Capsules. The active substance is nifuroxazide (nifuroxazide). Nifuroxazide is an antimicrobial agent, a derivative of nitrofuran. It blocks the activity of dehydrogenases and inhibits the respiratory chains, the tricarboxylic acid cycle and a number of other biochemical processes in the microbial cell. Destroys the membrane of microbial cells, reduces the production of toxins by microorganisms.

Tablets. The active substance is distigmine bromide. Acetylcholinesterase and pseudocholinesterase inhibitor. It has an indirect cholinomimetic effect due to reversible inhibition of cholinesterase and potentiation of the action of endogenous acetylcholine.

Tablets. The active substance is distigmine bromide. Acetylcholinesterase and pseudocholinesterase inhibitor. It has an indirect cholinomimetic effect due to reversible inhibition of cholinesterase and potentiation of the action of endogenous acetylcholine.

Film-coated tablets. Antiemetic - serotonin receptor antagonist. Stops vomiting that occurs when the parasympathetic nervous system is excited due to the release of serotonin by enterochromaffin cells. The active substance is granisetron.